MEDICA 2021
We are delighted to have re-registered for the annual MEDICA meeting in Düsseldorf, Germany. We can not wait to meet our customers and potential new partners there. Schedule a meeting with us in Germany and discuss your IVD test development or analytical performance challenges with us.
Future Diagnostics is the obvious choice for IVD assay developments
for start-ups, mid-sized biotech companies and multinationals in the global IVD medical device market. With 20+ years of expert experience and 150 IVD developments, our 85+ enthusiastic and highly skilled professionals are committed to accelerating healthcare innovation, providing high-quality assay development services.
Whether you need highly specialized knowledge or manpower to bring your concept to market, we are a trusted independent partner for any type of assay development using any type of technology on any type of analyzer. We are ISO 13485 certified and boast our own FDA registered manufacturing facility, offering small to medium scale pilot and commercial production capabilities. Immunoassays, point-of- care (POC) tests or IVDR analytical performance services – you can expect superior performance.
Why?
To ensure highest quality, conformity and transparency, we apply our proven New Product Development Process to all assay developments. Naturally, EN 13612:2002 and EN ISO 23640:2015 requirements and applicable CLSI guidelines are incorporated in this process, as is writing part of the technical file needed for IVD registration.
We are looking forward to share information with and get inspired by professionals at MEDICA. We welcome an opportunity to get in contact with start-ups, mid-sized biotech companies and multinationals in the global IVD medical device market and explore potential opportunities for collaborations.